Masami Nozaki

Hirakata, 5731121, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells.

LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells.

Journal: Scientific reports

Published: September 21, 2021

Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation.

Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation.

Journal: Cancers

Published: September 03, 2019

LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer.

LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer.

Journal: Oncotarget

Published: September 20, 2018

Molecularly-targeted therapy for the oral cancer stem cells.

Molecularly-targeted therapy for the oral cancer stem cells.

Journal: The Japanese dental science review

Published: May 23, 2017

Migration of oral squamous cell carcinoma cells are induced by HGF/c-Met signalling via lamellipodia and filopodia formation.

Migration of oral squamous cell carcinoma cells are induced by HGF/c-Met signalling via lamellipodia and filopodia formation.

Journal: Oncology reports

Published: November 15, 2016

Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.

Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.

Journal: Oncology reports

Published: April 26, 2016

Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells.

Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells.

Journal: Oncology letters

Published: January 28, 2016

Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.

Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.

Journal: International journal of oncology

Published: September 02, 2015

Interaction between basigin and monocarboxylate transporter 2 in the mouse testes and spermatozoa.

Interaction between basigin and monocarboxylate transporter 2 in the mouse testes and spermatozoa.

Journal: Asian journal of andrology

Published: July 25, 2015

The apoptotic initiator caspase-8: its functional ubiquity and genetic diversity during animal evolution.

The apoptotic initiator caspase-8: its functional ubiquity and genetic diversity during animal evolution.

Journal: Molecular biology and evolution

Published: September 11, 2014

Isolation and propagation of neural crest stem cells from mouse embryonic stem cells via cranial neurospheres.

Isolation and propagation of neural crest stem cells from mouse embryonic stem cells via cranial neurospheres.

Journal: Stem cells and development

Published: August 21, 2014

Resistance of oral squamous cell carcinoma cells to cetuximab is associated with EGFR insensitivity and enhanced stem cell-like potency.

Resistance of oral squamous cell carcinoma cells to cetuximab is associated with EGFR insensitivity and enhanced stem cell-like potency.

Journal: Oncology reports

Published: April 08, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026